Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol Dose Finding in Persistent Asthma
NCT01079130Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2010
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of indacaterol in asthma (6 arms), sponsored by Novartis. Primary endpoint: Trough Forced Expiratory Volume in 1 Second at Day 15. Started Feb 2010; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01079130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01079130.